Answers are grounded in this paper and cite their sources.
Shows budesonide reduces histamine release in human lung tissue, suggesting therapeutic potential.
IgE-receptor dependent, but not A23187-induced, histamine release from passively sensitized chopped human lung tissue, or from a dispersed lung cell population obtained from the tissue after enzymatic digestion, is reduced after incubation overnight of cells/tissue with the glucocorticosteroid budesonide (10(-7) M). Since the inhibitory effect of budesonide is reduced in the continuous presence of diluted reagin-rich serum used for passive sensitization, but not in the presence of heat-inactivated serum, it is suggested that the glucocorticosteroid acts by reducing the binding of IgE-antibody to the target cell(s).
No takes yet. Share an insight, caveat, or question.
Bergstrand et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: